Emtricitabine Withdrawn Phase 2 Trials for Hepatitis C Viral Infection / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00121017A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects